Patent · US Expired

Bradykinin analogs with non-peptide bond

US5750646A · kind A · utility

10Cited by
4References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 22, 1995
Grant dateMay 12, 1998
Priority date
Expiry dateMar 22, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A linear peptide which is an analog of a naturally occurring, biologically active peptide having an active site and a binding site responsible for the binding of the peptide to a receptor on a target cell, cleavage of a peptide bond in the active site to the naturally occurring peptide being unnecessary for in vivo biological activity, the analog having a non-peptide bond instead of a peptide bond between an amino acid of the active site and an adjacent amino acid, and having the same binding site as the naturally occurring peptide, so that the analog is capable of acting as a competitive inhibitor of the naturally occurring peptide by binding to the receptor and, by virtue of the non-peptide bond, failing to exhibit the in vivo activity of the naturally occurring peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.